MD ID: 3172198

Carsten Buhmann

graph of relations

Publications

  1. 2010
  2. Stalevo® zur Nacht bei Parkinson-Patienten

    Buhmann, C. & Roscher, T., 2010, In: Thieme Praxis Report. 1, p. 1-18

    Research output: SCORING: Contribution to journalSCORING: Journal articleEducation

  3. [When should we start medical treatment in Parkinson disease].

    Buhmann, C., Klucken, J., Korchounov, A., Schwarz, M., Vieregge, P. & Jost, W. H., 2010, In: FORTSCHR NEUROL PSYC. 78, 1, p. 31-33 1.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  4. 2009
  5. Mapping preclinical compensation in Parkinson's disease: an imaging genomics approach

    van Nuenen, B. F. L., van Eimeren, T., van der Vegt, J. P. M., Buhmann, C., Klein, C., Bloem, B. R. & Siebner, H. R., 01.01.2009, In: MOVEMENT DISORD. 24 Suppl 2, p. S703-10

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearch

  6. Beeinträchtigung der Geruchs- und Farbwahrnehmung bei genetischen und nicht genetischen Parkinsonsyndromen

    Tadic, V., Kertelge, L., Brüggemann, N., Schmidt, A., Wisse, C., Drude, L., van der Vegt, J. P. M., Schneider, S. A., Siebner, H. R., Lohmann, K., Buhmann, C., Hagenah, J., Klein, C. & Kasten, M., 2009, In: AKTUEL NEUROL. 2, p. 212

    Research output: SCORING: Contribution to journalConference abstract in journalResearch

  7. Effects of DBS, premotor rTMS, and levodopa on motor function and silent period in advanced Parkinson's disease.

    Bäumer, T., Hidding, U., Hamel, W., Buhmann, C., Moll, C., Gerloff, C., Orth, M., Siebner, H. R. & Münchau, A., 2009, In: MOVEMENT DISORD. 24, 5, p. 672-676 5.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  8. Equally normalized motor activation in medicated Parkin-associated and sporadic PD

    Eimeren Van, T., Buhmann, C., Hagenah, J. M., Pramstaller, P. P., Siebner, H. R. & Klein, C., 2009, In: MOVEMENT DISORD. 24, p. 217

    Research output: SCORING: Contribution to journalConference abstract in journalResearch

  9. State of the Art – M. Parkinson

    Buhmann, C., 2009, In: PharmaFokus ZNS. 6, p. 24-27

    Research output: SCORING: Contribution to journalSCORING: Journal articleEducation

  10. Successful GPi deep brain stimulation in a patient with adult onset primary axial dystonia.

    Zittel, S., Moll, C., Hamel, W., Buhmann, C., Engel, A. K., Gerloff, C. & Münchau, A., 2009, In: J NEUROL NEUROSUR PS. 80, 7, p. 811-812 7.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  11. Therapie geriatrischer Patienten mit M. Parkinson

    Buhmann, C., 2009, In: AKTUEL NEUROL. 36, p. 312-319

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearch

  12. 2008
  13. Diagnostik und Therapie des M. Parkinson beim älteren Patienten

    Buhmann, C., 2008, In: Neurogeriatrie. 5, 4, p. 135-143

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearch

  14. Initial experience with ropinirole PR (prolonged release).

    Jost, W. H., Buhmann, C., Fuchs, G., Greulich, W., Hummel, S., Korchounov, A., Müngersdorf, M., Schwarz, M. & Spiegel-Meixensberger, M., 2008, In: J NEUROL. 255, 5, p. 60-63 5.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  15. 2007
  16. Pallidal neuronal activity in myoclonus-dystonia syndrome

    Gulberti, A., Moll, C., Sharott, A., Hamel, W., Muenchau, A., Buhmann, C., Hidding, U., Zittel, S., Gerloff, C., Westphal, M., Müller, D. & Engel, A. K., 02.09.2007, IBAGS IX: 9th Triennial meeting of the International Basal Ganglia Society.

    Research output: SCORING: Contribution to book/anthologyConference contribution - PosterResearch

  17. arousal reaction due to electrical stimulation of the globus pallidus

    Moll, C., Sharrott, A., Buhmann, C., Hidding, U., Zittel, S., Westphal, M., Hamel, W. & Engel, A. K., 2007, In: ACTA PHYSIOL. p. 189

    Research output: SCORING: Contribution to journalConference abstract in journalResearch

  18. Klinik, Differentialdiagnostik und Therapie des M. Parkinson

    Buhmann, C., 2007, In: focus neurogeriatrie. 4, p. 2-8

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearch

  19. 2006
  20. Contrasting Parkin-associated and sporadic parkinsonism with fMRI during internally and externally cued action

    Eimeren Van, T., Klein, C., Buhmann, C., Erdmann, C., Büchel, C., Binkofski, F. & Siebner, H. R., 2006, In: HUM BRAIN MAPP.

    Research output: SCORING: Contribution to journalConference abstract in journalResearch

  21. Elevated levels of neural recognition molecule L1 in the cerebrospinal fluid of patients with Alzheimer disease and other dementia syndromes.

    Strekalova, H., Buhmann, C., Kleene, R., Eggers, C., Saffell, J., Hemperly, J., Weiller, C., Müller-Thomsen, T. & Schachner, M., 2006, In: NEUROBIOL AGING. 27, 1, p. 1-9 1.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  22. MEP latency shift after implantation of deep brain stimulation systems in the subthalamic nucleus in patients with advanced Parkinson's disease.

    Hidding, U., Bäumer, T., Siebner, H. R., Demiralay, C., Buhmann, C., Weyh, T., Moll, C., Hamel, W. & Münchau, A., 2006, In: MOVEMENT DISORD. 21, 9, p. 1471-1476 9.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  23. Role of functional imaging in neurological disorders.

    Weiller, C., May, A., Sach, M., Buhmann, C. & Rijntjes, M., 2006, In: J MAGN RESON IMAGING. 23, 6, p. 840-850 6.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  24. 2005
  25. Motor reorganization in asymptomatic carriers of a single mutant Parkin allele: a human model for presymptomatic parkinsonism.

    Buhmann, C., Binkofski, F., Klein, C., Büchel, C., van Eimeren, T., Erdmann, C., Hedrich, K., Kasten, M., Hagenah, J., Deuschl, G., Pramstaller, P. P. & Siebner, H. R., 2005, In: BRAIN. 128, 10, p. 2281-2290 10.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  26. 2004
  27. Abnormal excitability of premotor-motor connections in de novo Parkinson's disease.

    Buhmann, C., Gorsler, A., Bäumer, T., Hidding, U., Demiralay, C., Hinkelmann, K., Weiller, C., Siebner, H. R. & Münchau, A., 2004, In: BRAIN. 127, 12, p. 2732-2746 12.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  28. Increased prevalence of and gene transcription by Chlamydia pneumoniae in cerebrospinal fluid of patients with relapsing-remitting multiple sclerosis.

    Dong-Si, T., Weber, J., Liu, Y. B., Buhmann, C., Bauer, H., Bendl, C., Schnitzler, P., Grond-Ginsbach, C. & Grau, A. J., 2004, In: J NEUROL. 251, 5, p. 542-547 5.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  29. Plasma and CSF markers of oxidative stress are increased in Parkinson's disease and influenced by antiparkinsonian medication.

    Buhmann, C., Arlt, S., Kontush, A., Möller-Bertram, T., Sperber, S., Oechsner, M., Stuerenburg, H. J. & Beisiegel, U., 2004, In: NEUROBIOL DIS. 15, 1, p. 160-170 1.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  30. 2003
  31. CSF-tau, CSF-Abeta1-42, ApoE-genotype and clinical parameters in the diagnosis of Alzheimer's disease: combination of CSF-tau and MMSE yields highest sensitivity and specificity.

    Ganzer, S., Arlt, S., Schoder, V., Buhmann, C., Mandelkow, E-M., Finckh, U., Beisiegel, U., Naber, D. & Müller-Thomsen, T., 2003, In: J NEURAL TRANSM. 110, 10, p. 1149-1160 10.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  32. Dopaminergic response in Parkinsonian phenotype of Machado-Joseph disease.

    Buhmann, C., Bussopulos, A. & Oechsner, M., 2003, In: MOVEMENT DISORD. 18, 2, p. 219-221 2.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  33. Effects of mitoxantrone on multiple sclerosis patients' lymphocyte subpopulations and production of immunoglobulin, TNF-alpha and IL-10.

    Gbadamosi, J., Buhmann, C., Tessmer, W., Moench, A., Haag, F. & Heesen, C., 2003, In: EUR NEUROL. 49, 3, p. 137-141 3.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  34. Pharmacologically modulated fMRI--cortical responsiveness to levodopa in drug-naive hemiparkinsonian patients.

    Buhmann, C., Glauche, V., Stürenburg, H. J., Oechsner, M., Weiller, C. & Büchel, C., 2003, In: BRAIN. 126, 2, p. 451-461 2.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  35. Plasma amino acids in ecstasy users.

    Stuerenburg, H. J., Petersen, K., Buhmann, C., Rosenkranz, M., Bäumer, T. & Thomasius, R., 2003, In: NEUROENDOCRINOL LETT. 24, 5, p. 348-349 5.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  36. Therapy-related acute myelogenous leukaemia (t-AML) in a patient with multiple sclerosis treated with mitoxantrone.

    Heesen, C., Bruegmann, M., Gbadamosi, J., Koch, E., Mönch, A. & Buhmann, C., 2003, In: MULT SCLER J. 9, 2, p. 213-214 2.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  37. 2002
  38. COMT-inhibition increases serum levels of dihydroxyphenylacetic acid (DOPAC) in patients with advanced Parkinson's disease.

    Oechsner, M., Buhmann, C., Strauss, J. & Stuerenburg, H. J., 2002, In: J NEURAL TRANSM. 109, 1, p. 69-75 1.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  39. Increased lipid peroxidation in cerebrospinal fluid and plasma from patients with Creutzfeldt-Jakob disease.

    Arlt, S., Kontush, A., Zerr, I., Buhmann, C., Jacobi, C., Schröter, A., Poser, S. & Beisiegel, U., 2002, In: NEUROBIOL DIS. 10, 2, p. 150-156 2.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  40. Plasma concentrations of 5-HT, 5-HIAA, norepinephrine, epinephrine and dopamine in ecstasy users.

    Stuerenburg, H. J., Petersen, K., Bäumer, T., Rosenkranz, M., Buhmann, C. & Thomasius, R., 2002, In: NEUROENDOCRINOL LETT. 23, 3, p. 259-261 3.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  41. Visual recovery in a man with the rare combination of mtDNA 11778 LHON mutation and a MS-like disease after mitoxantrone therapy.

    Buhmann, C., Gbadamosi, J. & Heesen, C., 2002, In: ACTA NEUROL SCAND. 106, 4, p. 236-239 4.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  42. 2001
  43. Characterization of four lipoprotein classes in human cerebrospinal fluid.

    Koch, S., Donarski, N., Goetze, K., Kreckel, M., Stuerenburg, H. J., Buhmann, C. & Beisiegel, U., 2001, In: J LIPID RES. 42, 7, p. 1143-1151 7.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  44. Disease specific quality of life instruments in multiple sclerosis: validation of the Hamburg Quality of Life Questionnaire in Multiple Sclerosis (HAQUAMS).

    Gold, S. M., Heesen, C., Schulz, H., Guder, U., Mönch, A., Gbadamosi, J., Buhmann, C. & Schulz, K. H., 2001, In: MULT SCLER J. 7, 2, p. 119-130 2.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  45. Failure of ondansetron in treating cerebellar tremor in MS patients--an open-label pilot study.

    Gbadamosi, J., Buhmann, C., Moench, A. & Heesen, C., 2001, In: ACTA NEUROL SCAND. 104, 5, p. 308-311 5.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  46. 2000
  47. IL-1ra serum levels in disease stages of MS--a marker for progression?

    Heesen, C., Sieverding, F., Buhmann, C. & Gbadamosi, J., 2000, In: ACTA NEUROL SCAND. 101, 2, p. 95-97 2.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  48. Increased lipoprotein oxidation in Alzheimer's disease.

    Schippling, S., Kontush, A., Arlt, S., Buhmann, C., Stürenburg, H. J., Mann, U., Müller-Thomsen, T. & Beisiegel, U., 2000, In: FREE RADICAL BIO MED. 28, 3, p. 351-360 3.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  49. Workshop II: "neuroprotection"--the Lugano consensus.

    Riederer, P., Brücke, T., Buhmann, C., Müller, T., Schwartz, A., Storch, A. & Winner, B., 2000, In: J NEUROL. 247, 4, p. 36-37 4.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  50. 1999
  51. Current status of multiple sclerosis therapy in Germany: a national survey.

    Heesen, C., Hauer, S., Hadji-Abdolrahim, B., Berenbeck, C., Buhmann, C. & Emskotter, T., 1999, In: EUR J NEUROL. 6, 1, p. 35-38 1.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  52. 1998
  53. Computer-assisted three-dimensional reconstruction of the corticospinal system as a reference for CT and MRI.

    Buhmann, C. & Kretschmann, H. J., 1998, In: NEURORADIOLOGY. 40, 9, p. 549-557 9.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  54. 1991
  55. [Three-dimensional reconstructions in neuroanatomy]

    Kretschmann, H. J., Vogt, H., Schütz, T., Gerke, M., Riedel, A., Buhmann, C., Wesemann, M. & Müller, D., 1991, In: RADIOLOGE. 31, 10, p. 481-488 10.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

Previous 1 2 3 4 Next